The AI & Systems Bioinformatics Unit of the Translational Neuropharmacology Lab has released a new preprint introducing VirTarget, the first virus-informed pharmacogenomics framework designed to systematically evaluate how multiple sclerosis (MS) immunotherapies interact with Epstein-Barr virus (EBV)-driven pathogenesis. While EBV is increasingly recognized as a central driver of MS, current immunotherapies are prescribed without considering […]

Read More »

We’re excited to share our latest preprint, “VirTrack: A Framework for Inferring Viral Influence on Disease-Associated Transcriptomes — Clinical Type-Specific Epstein–Barr Virus Pathogenesis in Multiple Sclerosis,” now available on bioRxiv. This work, led by Dr. Anna Onisiforou, Head of our AI & Systems Bioinformatics Unit, represents a major advance in understanding how Epstein–Barr virus (EBV) […]

Read More »

Dr. Panos Zanos recently delivered a presentation on novel pharmacological therapies for brain diseases at the Ierokipio University in Paphos, Cyprus. The Ierokipio University is a lifelong learning initiative that brings scientific knowledge to the general public, fostering dialogue between researchers and community members on important health and medical topics. The presentation provided an overview […]

Read More »

Dr. Panos Zanos delivered an invited presentation at the 6th German-Cypriot Conference Psychotherapy Dialogues, titled “Neurobiology of Depression: Traditional & Rapid-acting Pharmacotherapies.” The presentation addressed a critical challenge in psychiatry: conventional antidepressants require three to four weeks to produce therapeutic effects, with approximately thirty percent of patients failing to respond. Dr. Zanos explored the neurobiological […]

Read More »

We are happy to share that Dr. Zanos, the Director of the Translational Neuropharmacology Lab, was recently featured in a Q&A article published by Nature Mental Health. The discussion explores our laboratory’s pioneering work on ketamine and its metabolites as novel treatments for brain pathologies, with particular emphasis on depression and substance use disorders. The […]

Read More »

We are pleased to share that the Translational Neuropharmacology Lab participated in the European Researchers’ Night (ERN) 2025, held on September 26, 2025, at the Cyprus State Fair in Nicosia. This annual event, organized by the Research and Innovation Foundation, brings research and innovation closer to the public through interactive demonstrations and activities. Our team […]

Read More »

We are pleased to announce that Dr. Zanos, Director of the Translational Neuropharmacology Lab, has been included in the Stanford University database of the world’s top 2% scientists, published by Elsevier. This prestigious recognition places Dr. Zanos among an elite group of researchers globally and reflects the significant impact of our laboratory’s research contributions to […]

Read More »

Our Master’s student and registered pharmacist, Georgios Kousathanas, was recently featured in the Cypriot “Politis” newspaper discussing one of our research topics on ketamine as an antidepressant treatment. The article, titled “Ketamine as a Model Drug for Rapid Antidepressant Action”, covers a part of the work being conducted in our laboratory on ketamine’s rapid-acting therapeutic […]

Read More »

We’re happy to share that our postdoctoral researcher Dr. Eleftheria Charalambous recently presented her latest findings at the World Federation of Societies of Biological Psychiatry (WFSBP) 2025 Congress. Her innovative research focuses on gut microbiome-wide association studies that identify specific viruses linked to mental health and brain aging. Dr. Charalambous’s work represents a significant advancement […]

Read More »

We are pleased to announce that Drs. Zanos and Apostolakis from the Translational Neuropharmacology Lab have been successfully selected and completed the “COST Academy – Leadership training workshop” for early-career investigators. This specialized training workshop was designed for young researchers to develop leadership skills for positions within COST consortia and broader research environments. Our laboratory’s […]

Read More »